| | |
ASPsiRNA information |
siRNA Id: | aspsirna3540
|
siRNA Name: | siC10
|
Mismatch information |
Wild siRNA (As strand 3'->5'): | GUCGUCGUCCCCCUGGAUAG
|
ASP-siRNA (As strand 3'->5'): | GUCGUCGUCGCCCUGGAUAG
|
Mismatch position in siRNA: | G11C |
Gene Information |
Gene Name | Ataxin-3 (ATXN3) |
Target Sequence (5'->3'): | CAGCAGCAGCAGGGGGACCTATCAGGAC
|
Wild allele (5'->3'): | CAGCAGCAGGGGGACCUAUC
|
Mutant allele (5'->3'): | CAGCAGCAGCGGGACCUAUC
|
Position of siRNA on target gene: | 976-995
|
Respective Gene/Protein Resources |
GenBank Accession: | NM_004993.5 |
Cytogenic location: | 14q32.12 |
Chromosomal coordinates: | 14:92,524,895-92,572,964 |
UniProt ID: | P54252 |
HUGO ID: | 7106 |
Reference SNp(RefSNP): | rs19392292 |
Disease/Mutation information |
Target Mutation: | c.G987C,c.892_894CAG(8_36) (p.Gln298_Gln305=)
|
Matation type/variant: | Microsatellite
|
Mutation at gene level: | NG_008198.2:g.40588_40590CAG(8_36)
|
Pathogenic status of mutation: | Disease causing trinucleotide CAG repeats
|
Disease: | Machado-Joseph Disease (MJD)/Spinocerebellar ataxia type 3 (SCA3) |
Clinical Resources |
ClinVar ID: | 3551 |
KEGG disease ID: | H00063 |
OMIM ID: | 109150 |
COSMIC: | ATXN3 |
DECIPHER: | ATXN3 |
GeneTests: | ATXN3 |
ASP siRNA details |
Mutant allele (5'->3'): | CAGCAGCAGCGGGACCUAUC
|
ASP-siRNA (As strand 3'->5'): | GUCGUCGUCGCCCUGGAUAG
|
Percentage efficacy of ASP-siRNA for mutant allele: | 66
|
Wild allele (5'->3'): | CAGCAGCAGGGGGACCUAUC
|
ASP-siRNA (As strand 3'->5'): | GUCGUCGUCGCCCUGGAUAG
|
Percentage efficacy of ASP-siRNA for wild allele: | 62
|
Relative difference: | 4
|
Wild siRNA details |
Wild allele (5'->3'): | CAGCAGCAGGGGGACCUAUC
|
Wild siRNA (As strand 3'->5'): | GUCGUCGUCCCCCUGGAUAG
|
Percentage efficacy of wild siRNA for wild allele: | 49
|
Wild allele (5'->3'): | CAGCAGCAGGGGGACCUAUC
|
ASP-siRNA (As strand 3'->5'): | GUCGUCGUCGCCCUGGAUAG
|
Percentage efficacy of Wild sirna for mutant allele: | 20
|
Relative difference : | 29
|
General information |
Mismatch incorporated in siRNA/Target: | siRNA |
Cell-line used: | Cos-7 |
Experimental technique used: | Western blot |
Transfection method: | Lipofectamine Plus |
siRNA expression method: | Integrated DNA Technologies |
Post-transfection duration: | 24-48 hours |
Concentration used: | 5mg |
Reference: | US20080176812A1 |
Delivery method: | Adenovirus associated shRNA delivery |
'Article title: | Allele-specific silencing of disease genes. |
'Authors: | Davidson Beverly L, Harper Scott, Gonzalez-Alegre Pedro,Miller Victor, Paulson Henry |
'Journal Reference: | US2008/0176812 A1 |
'